Schreck, I; Chudziak, D; Schneider, S et al.
Influence of aryl hydrocarbon expression and cell survival of mouse hepatoma cells.Toxicology. Bd. 259. H. 3. 2009 S. 91-6
Ostrau, C; Hülsenbeck, J; Herzog, M et al.
Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivoRadiother Oncol. Bd. 92. H. 3. 2009 S. 492-9
Batista, LF; Roos, WP; Kaina, B et al.
p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removalMol Cancer Res. Bd. 7. H. 2. 2009 S. 237-46
Stebel, A; Brachetti, C; Kunkel, M et al.
Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1ONCOLOGY REPORTS. Bd. 21. H. 1. 2009 S. 217-222
Oesch-Bartlomowicz, B; Oesch, F
Role of cAMP in mediating AHR signalingBiochem Pharmacol. Bd. 77. H. 4. 2009 S. 627-41
Fritz, G; Issinger, OG; Olsen, BB
Selectivity analysis of protein kinase CK2 inhibitors DMAT, TBB and resorufin in cisplatin-induced stress responsesINTERNATIONAL JOURNAL OF ONCOLOGY. Bd. 35. H. 5. 2009 S. 1151-1157
Fritz, G
Targeting the mevalonate pathway for improved anticancer therapy.Curr Cancer Drug Targets. Bd. 9. H. 5. 2009 S. 626-38
Naumann, SC; Roos, WP; Jost, E et al.
Temozolomide cells: response related to MGMT, MMR, DSBs, and p53Br J Cancer. Bd. 100. H. 2. 2009 S. 322-33
Roos, WP; Tsaalbi-Shtylik, A; Tsaryk, R et al.
The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugsMol Pharmacol. Bd. 76. H. 4. 2009 S. 927-34